Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 684508, 18 pages
http://dx.doi.org/10.1155/2014/684508
Review Article

Genus Caulophyllum: An Overview of Chemistry and Bioactivity

1Key Laboratory of Chinese Materia Medica, Heilongjiang University of Chinese Medicine, Ministry of Education, Harbin 150040, China
2Pharmaceutical College, Harbin Medical University, Harbin 150086, China

Received 21 January 2014; Accepted 2 April 2014; Published 4 May 2014

Academic Editor: Yong Jiang

Copyright © 2014 Yong-Gang Xia et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Tropicos, “Missouri Botanical Garden,” 2014, http://www.tropicos.org/NameSearch.aspx.
  2. J. I. Rader and R. S. Pawar, “Primary constituents of blue cohosh: quantification in dietary supplements and potential for toxicity,” Analytical and Bioanalytical Chemistry, vol. 405, no. 13, pp. 4409–4417, 2013. View at Publisher · View at Google Scholar
  3. A. Ankli, E. Reich, and M. Steiner, “Rapid high-performance thin-layer chromatographic method for detection of 5% adulteration of black cohosh with Cimicifuga foetida, C. heracleifolia, C. dahurica, or C. americana,” Journal of AOAC International, vol. 91, no. 6, pp. 1257–1264, 2008. View at Google Scholar · View at Scopus
  4. A. Chevallier, The Encyclopedia of Medicinal Plants, Dorling Kindersley Limited, London, UK, 1996.
  5. J.-J. Dugoua, D. Perri, D. Seely, E. Mills, and G. Koren, “Safety and efficacy of blue cohosh (Caulophyllum thalictroides) during pregnancy and lactation,” The Canadian Journal of Clinical Pharmacology, vol. 15, no. 1, pp. e66–e73, 2008. View at Google Scholar · View at Scopus
  6. M. Ganzera, H. R. Dharmaratne, N. P. Nanayakkara, and I. A. Khan, “Determination of saponins and alkaloids in Caulophyllum thalictroides (blue cohosh) by high-performance liquid chromatography and evaporative light scattering detection,” Phytochemical Analysis, vol. 14, no. 1, pp. 1–7, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. T. K. Jones and B. M. Lawson, “Profound neonatal congestive heart failure caused by maternal consumption of blue cohosh herbal medication,” The Journal of Pediatrics, vol. 132, no. 3, part 1, pp. 550–552, 1998. View at Publisher · View at Google Scholar · View at Scopus
  8. G. M. Chan and L. S. Nelson, “More on blue cohosh and perinatal stroke,” The New England Journal of Medicine, vol. 351, no. 21, pp. 2239–2241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Wu, Y. Hu, Z. Ali, I. A. Khan, A. J. Verlangeiri, and A. K. Dasmahapatra, “Teratogenic effects of blue cohosh (Caulophyllum thalictroides) in Japanese medaka (Oryzias latipes) are probably mediated through GATA2/EDN1 signaling pathway,” Chemical Research in Toxicology, vol. 23, no. 8, pp. 1405–1416, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Jiangsu New Medica College, Zhong Yao Da Ci Dian, Shanghai Science and Technology Press, Shanghai, China, 2009, (Chinese).
  11. X. F. Yang, Y. M. Ma, H. Xing, J. J. Liu, and Y. X. Kang, “Studies on triterpene saponins and their biological activity of Caulophyllum robustum,” Journal Shaannxi University Science Technology, vol. 31, no. 2, pp. 62–69, 2013 (Chinese). View at Google Scholar
  12. Y. C. Yang, S. Z. Chen, H. Y. Yang, and X. Xiong, “Experimental study on anti-inflammatory and analgesic effects of three kinds of organic extracts of Leontice robustum,” China Practice Medicine, vol. 32, no. 2, pp. 1–3, 2007 (Chinese). View at Google Scholar
  13. X.-L. Wang, B.-R. Liu, C.-K. Chen, J.-R. Wang, and S.-S. Lee, “Four new fluorenone alkaloids and one new dihydroazafluoranthene alkaloid from Caulophyllum robustum Maxim,” Fitoterapia, vol. 82, no. 6, pp. 793–797, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Yang, M. Liu, Y. Q. Zhang, and L. Lu, “Screening of some medicinal plants for acetylcholinesterase inhibition and antioxidant activity,” China Journal Experimental Traditional Medicine Formular, vol. 19, no. 2, pp. 213–218, 2013 (Chinese). View at Google Scholar
  15. Y. Zhang, L. He, L. Meng, W. Luo, and X. Xu, “Suppression of tumor-induced angiogenesis by taspine isolated from Radix et Rhizoma Leonticis and its mechanism of action in vitro,” Cancer Letters, vol. 262, no. 1, pp. 103–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Zhang, L. He, and Y. Zhou, “Taspine isolated from Radix et Rhizoma Leonticis inhibits growth of human umbilical vein endothelial cell (HUVEC) by inducing its apoptosis,” Phytomedicine, vol. 15, no. 1-2, pp. 112–119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Zhang, Y. Zhang, S. Zhang, S. Wang, and L. He, “Discovery of novel taspine derivatives as antiangiogenic agents,” Bioorganic & Medicinal Chemistry Letters, vol. 20, no. 2, pp. 718–721, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Zhang, Y. Zhang, Y. Shan, N. Li, W. Ma, and L. He, “Synthesis and preliminary biological evaluation of novel taspine derivatives as anticancer agents,” European Journal of Medicinal Chemistry, vol. 45, no. 7, pp. 2798–2805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Zhan, Y. Zhang, Y. Chen, N. Wang, L. Zheng, and L. He, “Activity of taspine isolated from Radix et Rhizoma Leonticis against estrogen-receptor-positive breast cancer,” Fitoterapia, vol. 82, no. 6, pp. 896–902, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Ali and I. A. Khan, “Alkaloids and saponins from blue cohosh,” Phytochemistry, vol. 69, no. 4, pp. 1037–1042, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. Matsuo, K. Watanabe, and Y. Mimaki, “Triterpene glycosides from the underground parts of Caulophyllum thalictroides,” Journal of Natural Products, vol. 72, no. 6, pp. 1155–1160, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. G. Y. Li, Y. G. Xia, J. Liang, Y. H. Zhang, and H. X. Kuang, “Simultaneous determination of five triterpenoid saponins in the root of Caulophyllum robustum Maxim by HPLC-ELSD,” in Phytochemicals: Occurrence in Nature, Health Effects and Antioxidant Properties, chapter 14, Nova Science, New York, NY, USA, 2013. View at Google Scholar
  23. C. Stevigny, C. Bailly, and J. Quetin-Leclercq, “Cytotoxic and antitumor potentialities of aporphinoid alkaloids,” Current Medicinal Chemistry: Anti-Cancer Agents, vol. 5, no. 2, pp. 173–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Ponnala and W. W. Harding, “A route to azafluoranthene natural products through direct arylation,” European Journal of Organic Chemistry, vol. 2013, no. 6, pp. 1107–1115, 2013. View at Publisher · View at Google Scholar
  25. E. J. Kennelly, T. J. Flynn, E. P. Mazzola et al., “Detecting potential teratogenic alkaloids from blue cohosh rhizomes using an in vitro rat embryo culture,” Journal of Natural Products, vol. 62, no. 10, pp. 1385–1389, 1999. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Zhao, “Nematicidal activity of quinolizidine alkaloids and the functional group pairs in their molecular structure,” Journal of Chemical Ecology, vol. 25, no. 10, pp. 2205–2214, 1999. View at Google Scholar · View at Scopus
  27. A. Al-Shamma, S. Drake, L. Guagliardi, L. Mitscher, and J. Swayze, “Antimicrobial alkaloids from Boehmeria cylindrica,” Phytochemistry, vol. 21, no. 2, pp. 485–487, 1982. View at Google Scholar · View at Scopus
  28. B. Wen, S. Wang, L. Wang, and L. He, “Preparative chromatographic isolation of caulophine from Radix caulophylli and its metabolism in vivo and in vitro,” Analytical Letters, vol. 44, no. 7, pp. 1277–1289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Lv, G. Li, Y. Zuo, and H. Kuang, “Determination the content of total saponins from Hong Mao Qi,” Acta Traditional Chinese Medicine, vol. 33, no. 5, pp. 14–15, 2005 (Chinese). View at Google Scholar
  30. J.-W. Jhoo, S. Sang, K. He et al., “Characterization of the triterpene saponins of the roots and rhizomes of blue cohosh (Caulophyllum thalictroides),” Journal of Agricultural and Food Chemistry, vol. 49, no. 12, pp. 5969–5974, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. Y. M. Ma, H. Xing, J. J. Liu, and Y. X. Kang, “Study on the chemical constitutes of C. robustum root,” Journal of Anhui AgriculturaL Science, vol. 40, no. 2, pp. 745–747, 2012 (Chinese). View at Google Scholar
  32. I. Abe, “Enzymatic synthesis of cyclic triterpenes,” Natural Product Reports, vol. 24, no. 6, pp. 1311–1331, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kushiro, M. Shibuya, and Y. Ebizuka, “β-amyrin synthase—cloning of oxidosqualene cyclase that catalyzes the formation of the most popular triterpene among higher plants,” European Journal of Biochemistry, vol. 256, no. 1, pp. 238–244, 1998. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Pollier and A. Goossens, “Oleanolic acid,” Phytochemistry, vol. 77, pp. 10–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. García-Granados, P. E. López, E. Melguizo, A. Parra, and Y. Simeó, “Partial synthesis of C-ring derivatives from oleanolic and maslinic acids. Formation of several triene systems by chemical and photochemical isomerization processes,” Tetrahedron, vol. 60, no. 7, pp. 1491–1503, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. G. Li, Y. Zhang, B. Yang et al., “Leiyemudanosides A-C, three new bidesmosidic triterpenoid saponins from the roots of Caulophyllum robustum,” Fitoterapia, vol. 81, no. 3, pp. 200–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  37. F. J. Dan, Z. J. Cai, Y. Tian, Z. Y. Guo, and L. J. Chu, “Chemical constituents of Caulophyllum robustum Maxim,” China Traditional Patent Medicine, vol. 33, no. 6, pp. 1011–1014, 2011 (Chinese). View at Google Scholar
  38. Y. M. Ma, H. Xing, J. J. Liu, and Y. X. Kang, “Study on the chemical constitutes of C. robustum root,” Journal of Anhui Agricultural Science, vol. 40, no. 2, pp. 745–747, 2012 (Chinese). View at Google Scholar
  39. F. J. Dan, Z. L. Jun, Z. J. Cai, and W. Yang, “Studies on antioxidant activity of Caulophyllum robustum polysaccharides,” Jiangsu Agricultural Science, vol. 38, no. 5, pp. 398–400, 2010 (Chinese). View at Google Scholar
  40. F. J. Dan, Z. J. Cai, G. Z. Liu, and D. Z. Zhou, “Studies on extraction process of polysaccharides from, “Hong Mao Qi” by ultrasonic technology,” Chinese Journal of New Drugs, vol. 18, no. 22, pp. 2172–2175, 2009 (Chinese). View at Google Scholar
  41. D. Pizzirani, M. Roberti, S. Grimaudo et al., “Identification of biphenyl-based hybrid molecules able to decrease the intracellular level of Bcl-2 protein in Bcl-2 overexpressing leukemia cells,” Journal of Medicinal Chemistry, vol. 52, no. 21, pp. 6936–6940, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Zhang, Y. Zhang, X. Pan, S. Wang, and L. He, “Synthesis and cytotoxic evaluation of novel symmetrical taspine derivatives as anticancer agents,” Medicinal Chemistry, vol. 7, no. 4, pp. 286–294, 2011. View at Publisher · View at Google Scholar · View at Scopus
  43. H. He, Y. Zhan, Y. Zhang, J. Zhang, and L. He, “Synthesis of novel taspine diphenyl derivatives as fluorescence probes and inhibitors of breast cancer cell proliferation,” Luminescence, vol. 27, no. 4, pp. 310–314, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. H. Z. He, N. Wang, J. Zhang, L. Zheng, and Y. M. Zhang, “Tas13D inhibits growth of SMMC-7721 cell via suppression VEGF and EGF expression,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 5, pp. 2009–2014, 2012. View at Google Scholar
  45. M. M. Anisimov, L. I. Strigina, S. I. Baranova, A. L. Kul'ga, and N. S. Chetyrina, “The antimicrobial activity of the triterpene glycosides of Caulophyllum robustum maxim,” Antibiotiki, vol. 17, no. 9, pp. 834–837, 1972. View at Google Scholar · View at Scopus
  46. Z. J. Cai, F. J. Dan, G. H. Chen, H. L. Li, Y. P. Xiong, and D. Z. Zhou, “Study on in vitro antibacterial activity of Caulophyllum robustum Maxim,” Journal of Anhui Agricultural Science, vol. 36, no. 35, pp. 15541–15543, 2008 (Chinese). View at Google Scholar
  47. G. P. Perdue, R. N. Blomster, D. A. Blake, and N. R. Farnsworth, “South American plants II: taspine isolation and anti-inflammatory activity,” Journal of Pharmaceutical Sciences, vol. 68, no. 1, pp. 124–126, 1979. View at Google Scholar · View at Scopus
  48. Y. Lee, J. C. Jung, Z. Ali, I. A. Khan, and S. Oh, “Anti-inflammatory effect of triterpene saponins isolated from blue cohosh (Caulophyllum thalictroides),” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 798192, 8 pages, 2012. View at Publisher · View at Google Scholar
  49. F. J. Dan, W. F. Yan, L. J. Chu, W. Y. Lu, and Z. J. Cai, “Studies on antioxidant activities of ethanol extract and different polar fractions of Caulophyllum robustum Maxmi.,” Science Technology Food Industry, vol. 32, no. 1, pp. 68–74, 2011 (Chinese). View at Google Scholar
  50. J. M. Rollinger, D. Schuster, E. Baier, E. P. Ellmerer, T. Langer, and H. Stuppner, “Taspine: bioactivity-guided isolation and molecular ligand-target insight of a potent acetylcholinesterase inhibitor from Magnolia x soulangiana,” Journal of Natural Products, vol. 69, no. 9, pp. 1341–1346, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. K.-W. Si, J.-T. Liu, L.-C. He et al., “Effects of caulophine on caffeine-induced cellular injury and calcium homeostasis in rat cardiomyocytes,” Basic & Clinical Pharmacology & Toxicology, vol. 107, no. 6, pp. 976–981, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. K. Gao, L.-C. He, and G.-D. Yang, “Screening the effective component of Leontice robustum by cell membrane chromatography,” Chinese Pharmaceutical Journal, vol. 38, no. 1, pp. 14–16, 2003 (Chinese). View at Google Scholar · View at Scopus
  53. R. Lin, J.-T. Liu, L.-C. He, W.-J. Gan, and H.-D. Yang, “Effects of Leontice robustum extract on the expression of NF-κB and nitroxide production in ECV injured by H2O2,” Chinese Pharmaceutical Journal, vol. 39, no. 11, pp. 826–828, 2004 (Chinese). View at Google Scholar · View at Scopus
  54. K. Si, J. Liu, L. He et al., “Caulophine protects cardiomyocytes from oxidative and ischemic injury,” Journal of Pharmacological Sciences, vol. 113, no. 4, pp. 368–377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Itokawa, Y. Ichihara, M. Mochizuki et al., “A cytotoxic substance from Sangre de Grado,” Chemical & Pharmaceutical Bulletin, vol. 39, no. 4, pp. 1041–1042, 1991. View at Google Scholar · View at Scopus
  56. Y. Zhang, L. He, and H. Wang, “Inhibitory effect of taspine on mouse S180 sarcoma and its mechanism,” China Journal of Chinese Materia Medica, vol. 32, no. 10, pp. 953–956, 2007 (Chinese). View at Google Scholar · View at Scopus
  57. Y. Zhang, L. He, L. Meng, and W. Luo, “Taspine isolated from Radix et Rhizoma Leonticis inhibits proliferation and migration of endothelial cells as well as chicken chorioallantoic membrane neovascularisation,” Vascular Pharmacology, vol. 48, no. 2-3, pp. 129–137, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. J. Zhao, L. Zhao, W. Chen, L. He, and X. Li, “Taspine downregulates VEGF expression and inhibits proliferation of vascular endothelial cells through PI3 kinase and MAP kinase signaling pathways,” Biomedicine & Pharmacotherapy, vol. 62, no. 6, pp. 383–389, 2008. View at Publisher · View at Google Scholar · View at Scopus
  59. W. Lu, L. C. He, C. H. Wang, Y. H. Li, and S. Q. Zhang, “The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice,” International Journal of Biological Macromolecules, vol. 43, no. 3, pp. 320–324, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. Y. Zhang, Q. Jiang, N. Wang, B. Dai, Y. Chen, and L. He, “Effects of taspine on proliferation and apoptosis by regulating caspase-3 expression and the ratio of Bax/Bcl-2 in A431 cells,” Phytotherapy Research, vol. 25, no. 3, pp. 357–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Zhang, J. Zhang, B. Dai, N. Wang, and L. He, “Anti-proliferative and apoptotic effects of the novel taspine derivative tas41 in the Caco-2 cell line,” Environmental Toxicology and Pharmacology, vol. 31, no. 3, pp. 406–415, 2011. View at Publisher · View at Google Scholar · View at Scopus
  62. W. Lu, B. Dai, W. Ma, and Y. Zhang, “A novel taspine analog, HMQ1611, inhibits growth of non-small cell lung cancer by inhibiting angiogenesis,” Oncology letters, vol. 4, no. 5, pp. 1109–1113, 2012. View at Google Scholar
  63. Y. Zhan, N. Wang, C. Liu, Y. Chen, L. Zheng, and L. He, “A novel taspine derivative, HMQ1611, suppresses adhesion, migration and invasion of ZR-75-30 human breast cancer cells,” Breast Cancer, 2012. View at Publisher · View at Google Scholar
  64. Y. M. Zhang, B. L. Dai, L. Zheng et al., “A novel angiogenesis inhibitor impairs lovo cell survival via targeting against human VEGFR and its signaling pathway of phosphorylation,” Cell Death and Disease, vol. 3, article e406, 2012. View at Publisher · View at Google Scholar
  65. V. L. Madgula, Z. Ali, T. Smillie, I. A. Khan, L. A. Walker, and S. I. Khan, “Alkaloids and saponins as cytochrome P450 inhibitors from blue cohosh (Caulophyllum thalictroides) in an in vitro assay,” Planta Medica, vol. 75, no. 4, pp. 329–332, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. W. Fayad, M. Fryknäs, S. Brnjic, M. H. Olofsson, R. Larsson, and S. Linder, “Identification of a novel topoisomerase inhibitor effective in cells overexpressing drug efflux transporters,” PLoS ONE, vol. 4, no. 10, article e7238, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. S. Tian, “Preparing wound care composition, comprises e.g. cleaning, drying and crushing kamuning, acutangular Anisodus root, soap thorn Leontice, Caulophyllum robustum and purslane, and taking tea oil and then filtering and heating,” Patent, 2012.
  68. B. H. Porras-Reyes, W. H. Lewis, J. Roman, L. Simchowitz, and T. A. Mustoe, “Enhancement of wound healing by the alkaloid taspine defining mechanism of action,” Proceedings of the Society for Experimental Biology and Medicine, vol. 203, no. 1, pp. 18–25, 1993. View at Google Scholar · View at Scopus
  69. A. J. Vaisberg, M. Milla, M. C. Planas et al., “Taspine is the cicatrizant principle in Sangre de Grado extracted from Croton lechleri,” Planta Medica, vol. 55, no. 2, pp. 140–143, 1989. View at Google Scholar · View at Scopus
  70. D. Aminin, I. Agafonova, S. Gnedoi, L. Strigina, and M. Anisimov, “The effect of pH on biological activity of plant cytotoxin cauloside C,” Comparative Biochemistry and Physiology A: Molecular & Integrative Physiology, vol. 122, no. 1, pp. 45–51, 1999. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Anisimov, E. Shentsova, and V. Shcheglov, “Mechanism of cytotoxic action of some triterpene glycosides,” Toxicon, vol. 16, no. 3, pp. 207–218, 1978. View at Google Scholar · View at Scopus
  72. J. Edmunds, “Blue cohosh and newborn myocardial infarction?” Midwifery Today with International Midwife, no. 52, pp. 34–35, 1999. View at Google Scholar · View at Scopus
  73. J. Zhou, J. B. Sun, P. Zheng et al., “Orthogonal array design for optimization of hollow-fiber-based liquid-phase microextraction combined with high-performance liquid chromatography for study of the pharmacokinetics of magnoflorine in rat plasma,” Analytical and Bioanalytical Chemistry, vol. 403, no. 7, pp. 1951–1960, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. W. Lu, L. C. He, and X.-M. Zeng, “HPLC method for the pharmacokinetics and tissue distribution of taspine solution and taspine liposome after intravenous administrations to mice,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 1, pp. 170–176, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. B. Wen, S. Wang, and L. He, “Development and validation of a solid phase extraction and LC-MS method for the determination of caulophine in rat plasma and tissue: application to study its pharmacokinetics,” Analytical Letters, vol. 43, no. 18, pp. 2872–2882, 2010. View at Publisher · View at Google Scholar · View at Scopus
  76. C. Li, L. He, H. Dong, and J. Jin, “Screening for the anti-inflammatory activity of fractions and compounds from Atractylodes macrocephala koidz,” Journal of Ethnopharmacology, vol. 114, no. 2, pp. 212–217, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. S. Wang, M. Sun, Y. Zhang, H. Du, and L. He, “A new A431/cell membrane chromatography and online high performance liquid chromatography/mass spectrometry method for screening epidermal growth factor receptor antagonists from Radix sophorae flavescentis,” Journal of Chromatography A, vol. 1217, no. 32, pp. 5246–5252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. X. Huang, L. Kong, X. Li, X. Chen, M. Guo, and H. Zou, “Strategy for analysis and screening of bioactive compounds in traditional Chinese medicines,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 812, no. 1-2, pp. 71–84, 2004. View at Publisher · View at Google Scholar · View at Scopus
  79. W. Yu, B. Yuan, X. Deng, L. He, Z. Youyi, and H. Qide, “The preparation of HEK293 α1A or HEK293 α1B cell membrane stationary phase and the chromatographic affinity study of ligands of α1 adrenoceptor,” Analytical Biochemistry, vol. 339, no. 2, pp. 198–205, 2005. View at Publisher · View at Google Scholar · View at Scopus
  80. B. X. Yuan, J. Hou, G. D. Yang, L. M. Zhao, and L. C. He, “Comparison of determination of drug-muscarinic receptor affinity by cell-membrane chromatography and by radioligand-binding assay with the cerebrum membrane of the rat,” Chromatographia, vol. 61, no. 7-8, pp. 381–384, 2005. View at Publisher · View at Google Scholar · View at Scopus
  81. X. Hou, S. Wang, J. Hou, and L. He, “Establishment of A431 cell membrane chromatography-RPLC method for screening target components from Radix Caulophylli,” Journal of Separation Science, vol. 34, no. 5, pp. 508–513, 2011. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Wang, J. Ren, M. Sun, and S. Wang, “A combined cell membrane chromatography and online HPLC/MS method for screening compounds from Radix Caulophylli acting on the human α1A-adrenoceptor,” Journal of Pharmaceutical and Biomedical Analysis, vol. 51, no. 5, pp. 1032–1036, 2010. View at Publisher · View at Google Scholar · View at Scopus
  83. H. Du, S. Wang, J. Ren, N. Lv, and L. He, “Revealing multi-binding sites for taspine to VEGFR-2 by cell membrane chromatography zonal elution,” Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 887-888, pp. 67–72, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. H. Du, N. Lv, S. Wang, and L. He, “Rapid characterization of a novel taspine derivative-HMQ1611 binding to EGFR by a cell membrane chromatography method,” Combinatorial Chemistry & High Throughput Screening, vol. 16, no. 4, pp. 324–329, 2013. View at Google Scholar
  85. M. S. Flom, R. W. Doskotch, and J. L. Beal, “Isolation and characterization of alkaloids from Caulophyllum thalictroides,” Journal of Pharmaceutical Sciences, vol. 56, no. 11, pp. 1515–1517, 1967. View at Google Scholar · View at Scopus
  86. Y. Li, Z. Hu, and L. He, “An approach to develop binary chromatographic fingerprints of the total alkaloids from Caulophyllum robustum by high performance liquid chromatography/diode array detector and gas chromatography/mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 43, no. 5, pp. 1667–1672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  87. F. B. Power and A. H. Salway, “The constituents of the rhizome and roots of Caulophyllum thalictroides,” Journal of the Chemical Society, vol. 103, pp. 191–209, 1913. View at Publisher · View at Google Scholar · View at Scopus
  88. S. Wang, B. Wen, N. Wang, J. Liu, and L. He, “Fluorenone alkaloid from Caulophyllum robustum Maxim. with anti-myocardial ischemia activity,” Archives of Pharmacal Research, vol. 32, no. 4, pp. 521–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Nagasawa, S. Urayama, T. Satake, and T. Murakarni, “New triterpenoid saponins in the rhizome and roots of Caulophyllum robustum Maxim,” Yakagaku Zasshi, vol. 88, no. 2, pp. 321–324, 1968. View at Google Scholar
  90. L. I. Strigina, N. S. Chetyrina, V. V. Isakov, Y. N. Elkin, A. K. Dzizenko, and G. B. Elyakov, “Cauloside D a new triterpenoid glycoside from Caulophyllum robustum maxim: identification of cauloside A,” Phytochemistry, vol. 14, no. 7, pp. 1583–1586, 1975. View at Publisher · View at Google Scholar · View at Scopus
  91. L. I. Strigina, N. S. Chetyrina, and V. V. Isakov, “Cauloside G, a new triterpene glycoside from Caulophyllum robustum identification of cauloside C,” Khimiya Prirodnykh Soedinenii, no. 5, pp. 619–623, 1976. View at Google Scholar
  92. N. S. Chetyrina and A. I. Kalinovskii, “Triterpene glycosides of Cauliphyllum robustum. The structures of caulosides B and C,” Chemistry of Natural Compounds, vol. 15, no. 2, pp. 146–148, 1979. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Wegner, M. Hamburger, O. Kunert, and E. Haslinger, “Tensioactive compounds from the aquatic plant Ranunculus fluitans L. (Ranunculaceae),” Helvetica Chimica Acta, vol. 83, no. 7, pp. 1454–1464, 2000. View at Google Scholar
  94. L. I. Strigina, N. S. Chetyrina, V. V. Isakov, A. K. Dzizenko, and G. B. Elyakov, “Caulophyllogenin: a novel triterpenoid from roots of Caulophyllum robustum,” Phytochemistry, vol. 13, no. 2, pp. 479–480, 1974. View at Google Scholar · View at Scopus